The Cost-Effectiveness of Low-Molecular-Weight Heparin vs Unfractionated Heparin in General and Orthopaedic Surgery: An Analysis for the German Healthcare System

Author： Szucs T.D.   Schramm W.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.40, Iss.1, 1999-07, pp. : 83-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis

By Attanasio E.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 57-68

Adis International

Access to resources Recommend Favorite

Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Wang Xu-Kai   Zhang Ye   Yang Cheng-Ming   Wang Yan   Liu Guang-Yao  

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 341-349

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin

By Jones Terry E   Smith Brian J   Polasek Jonathen F  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1887-1897

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome

By Brosa M.  

PharmacoEconomics, Vol. 20, Iss. 14, 2002-01 ,pp. : 979-987

Adis International

Access to resources Recommend Favorite